Etewa Samia E, Abd Allah Somia H, Badawey Maha S R, Shalaby Sally M, El-Shal Amal S, El Shafey Mahmoud A, Bareedy Mohamed H, Sarhan Mohamed H
J Egypt Soc Parasitol. 2016 Dec;46(3):693-716.
Vaccination against schistosomes can be targeted towards the prevention of infection and/or to the reduction of parasite fecundity and pathology. However, as eggs are responsible mainly for schistosomiasis pathology, so crude soluble egg antigen (SEA) seems suitable to be used as a potential vaccine. Many studies have provided new insights establishing a role for mesenchymal stem cells (MSCs) in liver regeneration and improvement of schistosomiasis hepatic fibrosis, in addition to the need for standardized and effective adjuvant-vaccine formulations. So, the aim of this work is to evaluate the effect of stem cells when used as an adjuvant of a potential anti-schistosomal vaccine (crude SEA) in murine models. The current work was carried out on 100 mice (30 males for harvesting MSCs + 70 females for seven study groups, each of 10). A schedule of vaccination and challenge infection was followed so, GI (control healthy), G2 (control infected only) infected subcutaneously with S. mansoni cercaria (80-90 Schistosoma mansoni cercariae suspended in 0.2 ml distilled Water), G 3 (FCA then infected) received Freund's complete adjuvant (FCA) then infected, G4 (MSCs then infected) received MSCs then infected, G5 (SEA then infected) received SEA vaccine then infected, G6 (SEA+FCA then infected) received SEA vaccine and FCA then infected, G7 (SEA+MSCs then infected) received SEA vaccine and MSCs then infected. The current work was assessed by histopathological study and morphometric analysis (using H&E and Masson's Trichrome stains) to highlight number, size and type of liver granulomas and percentage of liver fibrosis, immunological and molecular studies (RNA extraction, Re- verse Transcriptase and PCR technique) for detection of interleukin-10 mRNA gene expression in liver tissue by reverse transcriptase & polymerase chain reaction (RT & PCR). The results showed that a- SEA alone as a potential anti-schistosomal vaccine was more or less moderately protective, b- MSCs alone before the infection had mild prophylactic effects, c- MSCs as an adjuvant of the crude SEA increased its capabilities with highly significant results regarding the decrease in granuloma number, size, percentage and density of hepatic fi- brosis, and d-There was significant increase in IL-10 mRNA gene expression on using (SEA+MSCs) (G7) if compared to other tested groups.
针对血吸虫的疫苗接种可旨在预防感染和/或降低寄生虫的繁殖力及病理损害。然而,由于虫卵是导致血吸虫病病理损害的主要因素,因此粗制可溶性虫卵抗原(SEA)似乎适合用作潜在疫苗。许多研究提供了新的见解,证实间充质干细胞(MSCs)在肝脏再生和改善血吸虫病肝纤维化方面发挥作用,此外还需要标准化且有效的佐剂-疫苗配方。所以,本研究的目的是评估干细胞作为潜在抗血吸虫疫苗(粗制SEA)的佐剂在小鼠模型中的效果。本研究使用了100只小鼠(30只雄性用于采集间充质干细胞 + 70只雌性分为七个研究组,每组10只)。遵循了疫苗接种和攻击感染的时间表,即,GI(健康对照)、G2(仅感染对照)皮下感染曼氏血吸虫尾蚴(80 - 90条曼氏血吸虫尾蚴悬浮于0.2毫升蒸馏水中)、G3(先接种弗氏完全佐剂(FCA)然后感染)先接受弗氏完全佐剂(FCA)然后感染、G4(先接种间充质干细胞然后感染)先接受间充质干细胞然后感染、G5(先接种SEA然后感染)先接受SEA疫苗然后感染、G6(先接种SEA + FCA然后感染)先接受SEA疫苗和FCA然后感染、G7(先接种SEA + 间充质干细胞然后感染)先接受SEA疫苗和间充质干细胞然后感染。通过组织病理学研究和形态计量分析(使用苏木精-伊红染色和马松三色染色)评估本研究,以突出肝脏肉芽肿的数量、大小和类型以及肝纤维化的百分比,通过免疫和分子研究(RNA提取、逆转录酶和PCR技术),采用逆转录酶和聚合酶链反应(RT & PCR)检测肝组织中白细胞介素-10 mRNA基因表达。结果显示,a - 单独使用SEA作为潜在抗血吸虫疫苗具有或多或少的中度保护作用,b - 感染前单独使用间充质干细胞具有轻微的预防作用,c - 间充质干细胞作为粗制SEA的佐剂增强了其效果,在肝肉芽肿数量、大小、百分比及肝纤维化密度的降低方面取得了高度显著的结果,d - 与其他测试组相比,使用(SEA + 间充质干细胞)(G7)时白细胞介素-10 mRNA基因表达显著增加。